Modulating copper levels in the treatment of heart disease
An article published in Experimental Biology and Medicine provides new insights regarding the use of trientine (TETA), a copper chelator traditionally used to treat copper overload conditions such as Wilson's disease, in ...
Jan 10, 2019
0
0